Sentences with phrase «immunotherapeutics at»

Peter P. Lee, M.D., the Billy and Audrey L. Wilder Professor in Cancer Immunotherapeutics at City of Hope, has for two decades been interested in treating cancer by stimulating or enhancing a person's own immune system.

«Sodium fluoride is commonly found in toothpaste as it binds to calcium compounds in our teeth's enamel,» says Dr Anthony Davenport from the Department of Experimental Medicine and Immunotherapeutics at the University of Cambridge, who led the study.

Not exact matches

And he probably took several of his colleagues down a couple pegs, too — Collins regularly proselytized about the company, Innate Immunotherapeutics, to fellow House Republicans and convinced at least four of them to invest, as STAT News «Damian Garde reports.

The «stock tip» story shot back into the headlines again Tuesday after Collins mistakenly hit «reply all,» including reporter in an email intended for the head of Innate Immunotherapeutics, the company at the center of the accusations.

He was also overheard at the Capitol boasting about «how many millionaires I've made in Buffalo the past few months,» an apparent reference to Innate Immunotherapeutics, an Australian firm in which Collins is a major investor.

The committee is once again taking a shot at Collins involvement in the Australian pharmaceutical company Innate Immunotherapeutics.

At the recommendation of the office's report, the committee is continuing to investigate the allegations, which surround Collins» involvement with pharmaceutical company Innate Immunotherapeutics.

Investigations by senators and the media at the time also revealed that Rep. Chris Collins, R - N.Y., told Price and at least three other House members about the stock offerings in Innate Immunotherapeutics.

Included in those 2016 deals was the purchase of at least $ 500,000 in stock in Innate Immunotherapeutics, an Australian biotech firm in which Collins has long been the largest investor.

«Our findings are encouraging, as they suggest that entolimod can be safely combined with other chemotherapeutic, targeted or immunotherapeutic agents as treatment for advanced and very hard - to - treat cancers,» notes Dr. Adjei, who is Senior Vice President of Clinical Research and the Katherine Anne Gioia Chair in Cancer Medicine at Roswell Park.

«The bioinspired T cell - activating scaffolds developed by the Wyss Institute's Immunomaterials Platform could accelerate the success of many immunotherapeutic approaches in the clinic, with life - saving impact on a broad range of patients, in addition to advancing personalized medicine,» said Wyss Institute Founding Director Donald Ingber, M.D., Ph.D., who is also the Judah Folkman Professor of Vascular Biology at HMS and the Vascular Biology Program at Boston Children's Hospital, as well as Professor of Bioengineering at SEAS.

In 2011, he established the Immunotherapeutics Clinical Core, a specialized phase 1 outpatient unit at MSK that is focused on the conduct of novel immunotherapy trials, with a specific emphasis on pharmacodynamic biomarker identification.

Dr. Wolchok is the Lloyd J. Old / Virginia and Daniel K. Ludwig Chair in Clinical Investigation at Memorial Sloan Kettering Cancer Center (MSK); chief of the Melanoma and Immunotherapeutics Service at MSK; and an attending physician at MSK with expertise in the treatment of metastatic melanoma.

A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific protein.

Scientists at the UNC School of Medicine and NC State have created an injectable gel - like scaffold that can hold combination chemo - immunotherapeutic drugs and deliver them locally to tumours in a sequential manner.

Dr. Jedd D. Wolchok is the chief of the Melanoma and Immunotherapeutics Service, the Lloyd J. Old / Virginia and Daniel K. Ludwig Chair in Clinical Investigation, and director of the Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center.

Elucidating at the molecular level how these TLRs are precisely directed into the compartments that define their downstream signaling will enable us to better understand their biology and help modulate their activity during immunotherapeutic strategies.

Kochi About Blog Manzoor Koyakutty is a Professor at the Amrita Centre for Nanosciences and Molecular Medicine, Cochin, India, specializes in the area of Cancer nanomedicine & immunotherapeutics.

NovaVive Inc. announced that its anticancer immunotherapeutic for horses will be evaluated in a clinical study at Iowa State University College of Veterinary Medicine.

Kochi About Blog Manzoor Koyakutty is a Professor at the Amrita Centre for Nanosciences and Molecular Medicine, Cochin, India, specializes in the area of Cancer nanomedicine & immunotherapeutics.